Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo, Japan
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2022年 / 125卷 / 06期
关键词：
D O I：
10.1002/jso.26819
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1071 / 1071
页数：1
相关论文
共 50 条
  • [1] Response to "Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy"
    Narayanan, Sowmya
    Paniccia, Alessandro
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 1072 - 1072
  • [2] Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection
    Ren, Weizheng
    Xourafas, Dimitrios
    Ashley, Stanley W.
    Clancy, Thomas E.
    JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 605 - 615
  • [3] Neoadjuvant treatment of pancreatic ductal adenocarcinoma
    Katharina Kosma
    Sabine Thalhammer
    Thomas Gruenberger
    memo - Magazine of European Medical Oncology, 2022, 15 : 219 - 223
  • [4] Neoadjuvant treatment of pancreatic ductal adenocarcinoma
    Kosma, Katharina
    Thalhammer, Sabine
    Gruenberger, Thomas
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (03) : 219 - 223
  • [5] Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
    Silvestris, Nicola
    Longo, Vito
    Cellini, Francesco
    Reni, Michele
    Bittoni, Alessandro
    Cataldo, Ivana
    Partelli, Stefano
    Falconi, Massimo
    Scarpa, Aldo
    Brunetti, Oronzo
    Lorusso, Vito
    Santini, Daniele
    Morganti, Alessio
    Valentini, Vincenzo
    Cascinu, Stefano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 309 - 324
  • [6] Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma
    Izumo, Wataru
    Higuchi, Ryota
    Furukawa, Toru
    Yazawa, Takehisa
    Uemura, Shuichirou
    Shiihara, Masahiro
    Yamamoto, Masakazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 780 - 786
  • [7] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [8] The Prognostic Significance of Infiltrating Lymphocytes in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Therapy
    Nejati, Reza
    Halperin, Daniel M.
    Goldstein, Jennifer B.
    Wang, Hua
    Rashid, Asif
    Katz, Matthew H.
    Lee, Jeffrey E.
    Fleming, Jason B.
    Canales, Jaime Rodriguez
    Blando, Jorge
    Wistuba, Ignacio I.
    Maitra, Anirban
    Wolff, Robert A.
    Varadhachary, Gauri R.
    Wang, Huamin
    LABORATORY INVESTIGATION, 2016, 96 : 189A - 189A
  • [9] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [10] Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future
    Koukourakis, Ioannis M.
    Desse, Dimitra
    Papadimitriou, Marios
    Konstadoulakis, Manousos
    Zygogianni, Anna
    Papadimitriou, Christos
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
12345